<scp>RPL35A</scp> drives ovarian cancer progression by promoting the binding of <scp>YY1</scp> to <scp>CTCF</scp> promoter
Huijuan Wu(Shanghai Medical College of Fudan University), Qinmei Feng(Shanxi Provincial Cancer Hospital)
Cited by 5
Related Papers
Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation
|Cell Death Discovery|2020|18